Frederico O Gleber-Netto
Overview
Explore the profile of Frederico O Gleber-Netto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yaniv D, Mattson B, Talbot S, Gleber-Netto F, Amit M
Nat Rev Drug Discov
. 2024 Sep;
23(10):780-796.
PMID: 39242781
As the field of cancer neuroscience expands, the strategic targeting of interactions between neurons, cancer cells and other elements in the tumour microenvironment represents a potential paradigm shift in cancer...
2.
Islam S, Gleber-Netto F, Mulcahy C, Glaun M, Srivastava S, Hunt P, et al.
Sci Transl Med
. 2024 Jul;
16(758):eabq5585.
PMID: 39083586
The incidence of human papilloma virus-mediated oropharyngeal squamous cell carcinoma (OPSCC) has increased over the past 40 years, particularly among young individuals with a favorable prognosis; however, current therapy often...
3.
Michikawa C, Gleber-Netto F, Pickering C, Rao X, Wang J, Sikora A, et al.
Oral Oncol
. 2024 Apr;
153:106729.
PMID: 38663156
Background: Extranodal extension (ENE) of lymph node metastasis is one of the most reliable prognostic indicators for patients with locally advanced oral cancer. Although multiple reports have found a close...
4.
Gleber-Netto F, Nagarajan P, Sagiv O, Pickering C, Gross N, Ning J, et al.
Invest Ophthalmol Vis Sci
. 2024 Apr;
65(4):24.
PMID: 38597722
Purpose: Conjunctival squamous cell carcinoma (conjSCC) is more prevalent and aggressive in sub-Saharan African countries compared with the rest of the world. This study aims to compare the genomic, immunophenotypic,...
5.
Zhao M, Wang T, Gleber-Netto F, Chen Z, McGrail D, Gomez J, et al.
Nat Commun
. 2024 Jan;
15(1):180.
PMID: 38167338
Inactivating TP53 mutations leads to a loss of function of p53, but can also often result in oncogenic gain-of-function (GOF) of mutant p53 (mutp53) proteins which promotes tumor development and...
6.
Zhang X, Gleber-Netto F, Wang S, Jin K, Yang D, Gillenwater A, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568707
Head and neck squamous cell carcinoma (HNSCC), specifically in the oral cavity (oral squamous cell carcinoma, OSCC), is a common, complex cancer that significantly affects patients' quality of life. Early...
7.
Baruch E, Nagarajan P, Gleber-Netto F, Rao X, Xie T, Akhter S, et al.
Res Sq
. 2023 Jul;
PMID: 37503252
While the nervous system has reciprocal interactions with both cancer and the immune system, little is known about the potential role of tumor associated nerves (TANs) in modulating anti-tumoral immunity....
8.
Chen H, Zhao W, Naara S, Gleber-Netto F, Xie T, Ali S, et al.
JCO Precis Oncol
. 2023 Jun;
7:e2200490.
PMID: 37285560
Purpose: Although beta-blockers (BBs) have been hypothesized to exert a beneficial effect on cancer survival through inhibition of beta-adrenergic signaling pathways, clinical data on this issue have been inconsistent. We...
9.
Zhang X, Gleber-Netto F, Wang S, Martins-Chaves R, Gomez R, Vigneswaran N, et al.
Cancer Med
. 2023 Feb;
12(6):7508-7518.
PMID: 36721313
Background: Oral leukoplakia (OL) is associated with an increased risk for oral cancer (OC) development. Prediction of OL cancer progression may contribute to decreased OC morbidity and mortality by favoring...
10.
Brenes D, Nipper A, Tan M, Gleber-Netto F, Schwarz R, Pickering C, et al.
Oral Oncol
. 2022 Nov;
135:106232.
PMID: 36335817
Objective: Optical imaging studies of oral premalignant lesions have shown that optical markers, including loss of autofluorescence and altered morphology of epithelial cell nuclei, are predictive of high-grade pathology. While...